Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics ...Middle East

PR Newswire - News
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
Acquisition of Spyre and concurrent oversubscribed $210 million private investment positions the company to advance a leading inflammatory bowel disease (IBD) portfolio Spyre, the second spinout from Paragon Therapeutics, is advancing a pipeline of product candidates, led by SPY001 and...

Hence then, the article about aeglea biotherapeutics announces acquisition of spyre therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics )

Apple Storegoogle play

Last updated :

Also on site :